Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Jinfeng Pill in the Treatment of Perimenopausal Syndrome
NCT07606755Phase 4Recruiting
- Sponsor
- Tongji Hospital
- Start
- May 2026
- Primary completion
- May 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Jinfeng Pill in climacteric, sponsored by Tongji Hospital. Started May 2026; status: recruiting.
02
Drugs
Jinfeng Pill
03
Conditions
climacteric
Beyond the preview
Go deeper on NCT07606755.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07606755.